penicillin v has been researched along with 7432 s in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goldfarb, J; Gooch, WM; Mclinn, SE; Pichichero, ME; Reidenberg, BE; Rodriguez, W | 1 |
| Adam, D; Helmerking, M; Scholz, H | 2 |
1 review(s) available for penicillin v and 7432 s
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for penicillin v and 7432 s
| Article | Year |
|---|---|
Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group.
Topics: Adolescent; Ceftibuten; Cephalosporins; Child; Child, Preschool; Confidence Intervals; DNA, Bacterial; Double-Blind Method; Female; Humans; Male; Penicillin V; Penicillins; Pharyngitis; Prospective Studies; Scarlet Fever; Streptococcal Infections; Streptococcus pyogenes; Suspensions; Treatment Outcome | 1995 |
[Treatment of group A streptococcal tonsillopharyngitis. 5 days cephalosporin is as effective as 10 days penicillin].
Topics: Ceftibuten; Cephalosporins; Child; Drug Administration Schedule; Humans; Penicillin V; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2001 |
[Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis].
Topics: Adolescent; Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Chi-Square Distribution; Child; Child, Preschool; Data Interpretation, Statistical; Follow-Up Studies; Humans; Infant; Penicillin V; Pharyngitis; Recurrence; Serotyping; Streptococcal Infections; Streptococcus pyogenes; Time Factors; Tonsillitis | 2001 |
2 other study(ies) available for penicillin v and 7432 s
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |